The skeptic's objection: creatine is a bodybuilding supplement with no relevance outside of athletics. This objection was reasonable twenty years ago and is empirically wrong now.

A 2018 systematic review and meta-analysis examining creatine supplementation and cognitive function found significant improvements in short-term memory and reasoning tasks — particularly in adults under conditions of sleep deprivation or metabolic stress. A 2006 trial demonstrated meaningful cognitive performance preservation after 24 hours of sleep deprivation in the creatine group versus placebo. These are not gym outcomes. The mechanism — expanding the phosphocreatine buffer in brain cells — applies identically to neurons and muscle fibers.

The skeptic's objection: adaptogens are a marketing category with no mechanistic basis. This conflates the category with the compound. Ashwagandha specifically — standardized to withanolide content — has one of the cleanest evidence bases in the functional supplement space.

Chandrasekhar et al. (2012), a double-blind placebo-controlled trial in 64 adults, found a 28% reduction in serum cortisol at 600mg/day of KSM-66 extract over 60 days, alongside significant improvements in stress, anxiety, and sleep quality scores. This finding has been replicated across multiple trials with consistent effect sizes. The mechanism — withanolides sensitizing glucocorticoid receptors and modulating HPA axis activity — is characterized at the molecular level. This is not folklore.

The skeptic's objection: functional mushroom supplements are wellness marketing with no clinical support. The objection is fair for most of the mushroom supplement market. Lion's Mane specifically has a characterized mechanism and replicated clinical findings.

Mori et al. (2009) — the landmark trial — showed significant improvements in cognitive performance scores in adults with mild cognitive impairment over 16 weeks at 3g/day of powder. A 2023 trial in Nutrients demonstrated acute cognitive improvements in healthy adults aged 18–45 within 60 minutes of a single dose. The mechanism — hericenones and erinacines stimulating endogenous NGF synthesis — is established at the molecular level. This is not the same as claiming any mushroom blend improves memory.

The skeptic's objection: collagen is just protein, and dietary protein gets digested into amino acids — there's no reason supplemental collagen would specifically benefit skin. This objection was reasonable before the bioavailability research existed. Proksch et al. (2014) and subsequent trials changed the picture.

Hydroxyproline-containing peptides — specific short-chain sequences from hydrolyzed collagen — survive digestion and appear in blood within 60 minutes of oral ingestion. In skin tissue, these peptides were detected in the dermis specifically. They appear to act as signaling molecules that upregulate fibroblast activity — the cells responsible for collagen synthesis — rather than simply providing amino acid building blocks. At 12 weeks in double-blind trials, measurable improvements in dermal collagen density and skin elasticity were demonstrated versus placebo.

The skeptic's objection: fish oil studies have been inconsistent and the cardiovascular benefit claims are overblown. This objection was more defensible before 2019. The VITAL trial — 25,871 participants, median 5.3 years follow-up — found a 28% reduction in myocardial infarction risk in the omega-3 supplementation group versus placebo. This is the largest and most rigorous omega-3 trial conducted, and its cardiovascular findings are not subtle.

Separately, the cognitive and anti-inflammatory evidence for EPA and DHA is consistent across dozens of trials — DHA is a structural component of neuronal cell membranes; EPA is the primary anti-inflammatory omega-3 fatty acid. The mechanism is real; the debate was largely about dose and formulation, not mechanism.

The skeptic's objection: turmeric doesn't absorb well enough to produce meaningful effects. This is true of raw turmeric and curcumin without piperine. With piperine co-formulation, the objection is obsolete.

A landmark study demonstrated that piperine — the active compound in black pepper — increases curcumin bioavailability by approximately 2,000% by inhibiting hepatic and intestinal glucuronidation (the metabolic process that otherwise rapidly degrades curcumin before it can reach systemic circulation). With this co-formulation, curcumin reaches plasma concentrations sufficient to produce its documented NF-kB inhibitory and anti-inflammatory effects. Without it, the dose largely passes through without meaningful absorption. The compound is effective; the delivery requirement is non-negotiable.